Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyu-Pyo Kim

Showing results (61-70 of 217) with videos related to

Pageof 22
Sort By:
Targeted Oncology|December 18, 2023
Efficacy and Safety of Lu-177 DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Unresectable or Metastatic Neuroendocrine Tumors in KoreaYeokyeong Shin, Bo Hyun Moon, Baek-Yeol Ryoo, et al.
BMC Gastroenterology|November 25, 2017
Primary tumor location predicts poor clinical outcome with cetuximab in RAS wild-type metastatic colorectal cancerDalyong Kim, Sun Young Kim, Ji Sung Lee, et al.
Frontiers in Oncology|August 9, 2021
Expression of HER2 and Mismatch Repair Proteins in Surgically Resected Gallbladder AdenocarcinomaYou-Na Sung, Sung Joo Kim, Sun-Young Jun, et al.
Therapeutic Advances in Medical Oncology|June 12, 2020
Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysisHeejung Chae, Hyehyun Jeong, Jaekyung Cheon, et al.
Investigational New Drugs|January 16, 2014
A prospective multicenter phase II study of sunitinib in patients with advanced aggressive fibromatosisJae-Cheol Jo, Yong Sang Hong, Kyu-Pyo Kim, et al.
Cancer Research and Treatment|February 13, 2015
Regorafenib as Salvage Treatment in Korean Patients with Refractory Metastatic Colorectal CancerSeung Tae Kim, Tae Won Kim, Kyu-pyo Kim, et al.
Cancer Medicine|January 3, 2025
Serum 25-Hydroxyvitamin D Levels and Survival Outcomes in Advanced Biliary Tract Cancer: Results From the NIFTY TrialSo Heun Lee, Jaekyung Cheon, Ilhwan Kim, et al.
European Radiology|April 26, 2018
Clinical impact of preoperative liver MRI in the evaluation of synchronous liver metastasis of colon cancerCherry Kim, So Yeon Kim, Min-Ju Kim, et al.
Translational Oncology|February 8, 2018
Mutational Profiling of Malignant Mesothelioma Revealed Potential Therapeutic Targets in EGFR and NRASJeong Eun Kim, Deokhoon Kim, Yong Sang Hong, et al.
Clinical Therapeutics|April 28, 2009
An open-label, single-dose, parallel-group, dose-increasing study comparing the pharmacokinetics and tolerability of pilsicainide hydrochloride in healthy Korean and Japanese male subjectsBo-Hyung Kim, Jung-Ryul Kim, Kyoung Soo Lim, et al.
Pageof 22

Showing results (61-70 of 217) with videos related to

Sort By:
Pageof 22
Targeted Oncology|December 18, 2023
Efficacy and Safety of Lu-177 DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Unresectable or Metastatic Neuroendocrine Tumors in KoreaYeokyeong Shin, Bo Hyun Moon, Baek-Yeol Ryoo, et al.
BMC Gastroenterology|November 25, 2017
Primary tumor location predicts poor clinical outcome with cetuximab in RAS wild-type metastatic colorectal cancerDalyong Kim, Sun Young Kim, Ji Sung Lee, et al.
Frontiers in Oncology|August 9, 2021
Expression of HER2 and Mismatch Repair Proteins in Surgically Resected Gallbladder AdenocarcinomaYou-Na Sung, Sung Joo Kim, Sun-Young Jun, et al.
Therapeutic Advances in Medical Oncology|June 12, 2020
Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysisHeejung Chae, Hyehyun Jeong, Jaekyung Cheon, et al.
Investigational New Drugs|January 16, 2014
A prospective multicenter phase II study of sunitinib in patients with advanced aggressive fibromatosisJae-Cheol Jo, Yong Sang Hong, Kyu-Pyo Kim, et al.
Cancer Research and Treatment|February 13, 2015
Regorafenib as Salvage Treatment in Korean Patients with Refractory Metastatic Colorectal CancerSeung Tae Kim, Tae Won Kim, Kyu-pyo Kim, et al.
Cancer Medicine|January 3, 2025
Serum 25-Hydroxyvitamin D Levels and Survival Outcomes in Advanced Biliary Tract Cancer: Results From the NIFTY TrialSo Heun Lee, Jaekyung Cheon, Ilhwan Kim, et al.
European Radiology|April 26, 2018
Clinical impact of preoperative liver MRI in the evaluation of synchronous liver metastasis of colon cancerCherry Kim, So Yeon Kim, Min-Ju Kim, et al.
Translational Oncology|February 8, 2018
Mutational Profiling of Malignant Mesothelioma Revealed Potential Therapeutic Targets in EGFR and NRASJeong Eun Kim, Deokhoon Kim, Yong Sang Hong, et al.
Clinical Therapeutics|April 28, 2009
An open-label, single-dose, parallel-group, dose-increasing study comparing the pharmacokinetics and tolerability of pilsicainide hydrochloride in healthy Korean and Japanese male subjectsBo-Hyung Kim, Jung-Ryul Kim, Kyoung Soo Lim, et al.
Pageof 22